Viewing Study NCT04557735


Ignite Creation Date: 2025-12-24 @ 10:09 PM
Ignite Modification Date: 2025-12-30 @ 2:25 AM
Study NCT ID: NCT04557735
Status: COMPLETED
Last Update Posted: 2025-10-02
First Post: 2020-09-02
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Study of Ravulizumab in Pediatric Participants With HSCT-TMA
Sponsor: Alexion Pharmaceuticals, Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module